Skip to main content

Year: 2019

Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO

Press Release13 December 2019Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEOThe Board of Directors of Immunicum announced today that, by mutual agreement, Carlos de Sousa has resigned as CEO of Immunicum effective immediately. The Board has appointed Alex Karlsson-Parra, Immunicum’s Chief Scientific Officer, as acting CEO. The Board will begin recruitment of a new CEO shortly.“We thank Carlos for his efforts that have put Immunicum in a strong position, with competitive clinical results and a competent and experienced organization with the ability to develop the company further. Over the past three years as CEO, Carlos has significantly contributed to steering the company through a demanding phase in the development of the drug candidate ilixadencel. Now is the right time to let a new CEO take Immunicum through its...

Continue reading

Carlos de Sousa avgår som vd för Immunicum AB (publ)

Pressmeddelande13 december 2019Carlos de Sousa avgår som vd för Immunicum AB (publ)Styrelsen i Immunicum har kommit överens med Carlos de Sousa om att han lämnar rollen som verkställande direktör för Immunicum med omedelbar verkan. Styrelsen har utsett Alex Karlsson-Parra, idag forskningschef, till tillförordnad vd. Styrelsen kommer att inleda rekrytering av en ny vd inom kort.“Vi tackar Carlos för hans insatser som har lett till att Immunicum i dag står väl rustat med konkurrenskraftiga kliniska resultat i ryggen och en kompetent och erfaren organisation för att utveckla bolaget vidare. De tre senaste åren som vd har Carlos gjort en betydelsefull insats genom att lotsa bolaget genom en krävande fas i utvecklingen av läkemedelskandidaten Ilixadencel. Nu är ett bra tillfälle att låta en ny kraft ta över vd-rollen för att ta nästa steg...

Continue reading

Øresunds Bridge CEO resigns in 2020

Øresunds Bridge CEO resigns in 2020CEO of the Øresunds Bridge Consortium Caroline Ullman-Hammer resigns after 13 profitable years in the Swedish-Danish company. She will remain in her role until further but will resign when a new CEO is appointed during 2020.Caroline Ullman-Hammer joined the Øresund Bridge in 2007 and has since then contributed to raising traffic volumes, increased results and significant growth in customers. The Øresunds Bridge has over 550.000 BroPas-customers.“We thank Caroline Ullman-Hammer for the very fine efforts. Under Caroline’s management the bridge has positioned itself clearly – with several years’ increased traffic, lowered operating costs and significantly more customers. She is responsible for the commercially healthy company, on which the bridge safely leans”, says Peter Frederiksen,...

Continue reading

Øresundsbrons administrerende direktør træder tilbage i 2020

Øresundsbrons administrerende direktør træder tilbage i 2020Øresundsbro Konsortiets administrerende direktør Caroline Ullman-Hammer har valgt at sige sit job op efter 13 fremgangsrige år i det svensk-danske selskab. Hun fortsætter i sin rolle indtil videre, men forlader selskabet, når en ny direktør tiltræder i 2020.Caroline Ullman-Hammer tiltrådte som administrerende direktør for Øresundsbron i 2007 og har siden da bidraget til Øresundsforbindelsens stigende trafikvolumen, forbedrede resultater og en stor kundetilgang. Øresundsbron har over 550.000 BroPas-kunder i dag.“Vi takker Caroline Ullman-Hammer for den meget fine indsats. Under Carolines ledelse har broen positioneret sig ganske tydeligt – med flere års øget trafik, lavere driftsomkostninger og mange flere kunder. Hun står bag den forretningsmæssigt sunde virksomhed, som...

Continue reading

FirstFarms A/S is making an upward adjustment of the expectations for 2019 based on still increasing pig prices

FirstFarms expects an improved result for 2019 based on still increasing pig prices.Based on the above, FirstFarms adjusts upwards the expectations with DKK 5 million to an EBITDA of DKK 95-100 million and an EBIT of DKK 48-53 million compared to previously DKK 90-95 million and DKK 43-48 million, as stated in company announcement no. 13/2019.Best regards,FirstFarms A/SFor further information:Please visit our website www.firstfarms.com or contact CEO Anders H. Nørgaard on telephone +45 75 86 87 87.About FirstFarms:FirstFarms is a Danish stock exchange listed company, which purchases and operates agriculture in Eastern Europe. We develop the individual farms to modern and sustainable businesses that deliver milk, meat and grains of the highest quality to the consumers’ dinner tables.                                         Attachment(18)...

Continue reading

FirstFarms A/S opjusterer forventningerne til 2019 med baggrund i stadig stigende svinepriser

FirstFarms forventer et forbedret resultat for 2019 med baggrund i stadig stigende svinepriser.FirstFarms opjusterer, på baggrund af ovenstående, forventningerne med 5 mio. kr. til et EBITDA på 95-100 mio. kr. og et EBIT på 48-53 mio. kr. mod tidligere 90-95 mio. kr. og 43-48 mio. kr., som oplyst i selskabsmeddelelse nr. 13/2019.Med venlig hilsen,FirstFarms A/SFor yderligere information:Se venligst vores hjemmeside www.firstfarms.dk ellerkontakt adm. direktør Anders H. Nørgaard på telefon +45 75 86 87 87.                                               Om FirstFarms:FirstFarms er et dansk børsnoteret selskab, der opkøber og driver landbrug i Østeuropa. Vi udvikler de enkelte landbrug til moderne, bæredygtige virksomheder, der leverer mælk, kød og korn af bedste kvalitet til forbrugernes middagsborde.                                   Vedhæftet...

Continue reading

Equinor’s share saving plan allocates shares

The shares purchased by DNB on behalf of Equinor (OSE: EQNR, NYSE: EQNR) on 10 December 2019 for use in the group’s Share Saving Plan, have on 13 December 2019 been distributed to the employees in accordance with their savings amount.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentPrimary insiders overview

Continue reading

Granted NOK 37.6 million to deliver hydrogen to ferries and cruise ships in the Geirangerfjord

The Hellesylt Hydrogen Hub, a consortium of leading players in the hydrogen field, including Hexagon, has been awarded NOK 37.6 million under the PILOT-E funding scheme for the development of a hydrogen production facility that can deliver hydrogen to ferries and cruise ships in the Geirangerfjord, as well as to other mobility applications. The ambition is to achieve zero-emission operations in the Geirangerfjord, one of two World Heritage Fjords in Norway, by producing green hydrogen locally.See attached press release by Flakk Gruppen for more information.For more information:Hiva Ghiri, VP Investor Relations, Hexagon CompositesTelephone: +47 958 66 790 | hiva.ghiri@hexagongroup.comSolveig D Saether, Communication Manager, Hexagon Composites ASATelephone: +47 906 34 977 | solveig.saether@hexagongroup.comAbout Hexagon CompositesHexagon...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.